Nearwater Capital Markets, Ltd

Position in CELC — Celcuity Inc.

CIK 1915842 NEW YORK, NY

Position in CELC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$104,620

-$53,895,014 QoQ

Shares Held

1,000

-99.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#223

of 273 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nearwater Capital Markets, Ltd holds $476,932,369 across 5 Biotechnology names. CELC ranks #5 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,097,000	$392,726,160
2	ROIV	Roivant Sciences Ltd.	1,500,000	$53,085,000
3	NKTR	Nektar Therapeutics	261,500	$18,255,315
4	ARQT	Arcutis Biotherapeutics, Inc.	486,700	$12,761,274
5	CELC	Celcuity Inc. This page	1,000	$104,620

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$104,620	1,000	-99.8%	Shares	Sole	2026-08-14
2026-03-31	$53,999,634	473,100	-9.1%	Shares	Sole	2026-05-15
2025-12-31	$51,884,748	520,200	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.